The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 25 , ISSUE 7 ( July, 2024 ) > List of Articles

ORIGINAL RESEARCH

Evaluation of Crestal Bone Loss after Placement of Bone Graft around the Oral Implant with/without Platelet-rich Plasma

Mohammad Jalaluddin, Naman Awasthi, Ibrahim S Aljulayfi, Naveen EP Cheriyath, Ananjana Balakrishnan, Angitha Koodali

Keywords : Bone graft, Crestal bone, Oral implant, Platelet-rich plasma, Tricalcium phosphate

Citation Information : Jalaluddin M, Awasthi N, Aljulayfi IS, Cheriyath NE, Balakrishnan A, Koodali A. Evaluation of Crestal Bone Loss after Placement of Bone Graft around the Oral Implant with/without Platelet-rich Plasma. J Contemp Dent Pract 2024; 25 (7):645-648.

DOI: 10.5005/jp-journals-10024-3694

License: CC BY-NC 4.0

Published Online: 30-10-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aim: The current investigation aimed to evaluate the crestal bone loss after placement of bone graft around the oral implant with/without platelet-rich plasma (PRP). Materials and methods: Forty patients seeking for crown supported by dental implants to replace at least one lost tooth were included in the present study. The participants were divided into two groups at random (n = 20): Group I: Received tricalcium phosphate (TCP) along with PRP and group II: Received TCP without PRP. Digital radiographs were used to quantify the crestal bone levels on the mesial, distal, buccal, and lingual side of each implant after surgery, also at 3 months and 6 months follow-up period. Data were recorded and subjected to statistical analysis. Results: After 3 months, the crestal bone level in TCP with PRP group, mesial side was 1.02 ± 0.18, distal was 1.14 ± 0.11, buccal was 1.18 ± 0.12 and lingual was 1.16 ± 0.16. In only TCP group, mesial side was 1.14 ± 0.02, distal was 1.24 ± 0.10, buccal was 1.38 ± 0.12 and lingual was 1.30 ± 0.08. There was a statistically significant difference between the two groups. After 6 months, the crestal bone level in TCP with PRP group, mesial side was 1.26 ± 0.02, distal was 1.38 ± 0.14, buccal was 1.44 ± 0.09, and lingual was 1.52 ± 0.12. In only TCP group, mesial side was 1.40 ± 0.10, distal was 1.56 ± 0.12, buccal was 1.62 ± 0.06, and lingual was 1.84 ± 0.04. There was a statistically significant difference between the two groups at 3 and 6 months. Conclusion: On conclusion, considerable crestal bone loss was observed in both treatment regimens. But TCP bone graft with PRP group found decreased bone loss around the dental implants than only TCP bone graft group. Clinical significance: The most important aspects of controlling crestal bone loss are choosing the right implant design and bone transplant materials. Also, platelet-rich fibrin plays an important role in accelerating the healing process, improving bone regeneration, and repairing as it contains a high amount of growth factors and inflammatory chemicals.


PDF Share
  1. Kim SY, Dodson TB, Do DT, et al. Factors associated with crestal bone loss following dental implant placement in a longitudinal follow-up study. J Oral Implantol 2015;41(5):579–585. DOI: 10.1563/AAID-JOI-D-12-00193.
  2. Quoc JB, Vang A, Evrard L. Peri-implant bone loss at implants placed in preserved alveolar bone versus implants placed in native bone: A retrospective radiographic study. Open Dent J 2018;12:529–545. DOI: 10.2174/1874210601812010529.
  3. Klimecs V, Grishulonoks A, Salma I, et al. Bone loss around dental implants 5 years after implantation of biphasic calcium phosphate (HAp/βTCP) granules. J Healthc Eng 2018;1–7. DOI: 10.1155/2018/4804902.
  4. Sheikh Z, Abdallah MN, Hanafi AA, et al. Mechanisms of in vivo degradation and resorption of calcium phosphate based biomaterials. Materials 2015;8:7913–7925. DOI: 10.3390/ma8115430.
  5. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):e37–e44. DOI: 10.1016/j.tripleo.2005.07.008.
  6. Boora P, Manu Rathee M, Bhoria M. Effect of platelet rich fibrin (PRF) on peri-implant soft tissue and crestal bone in one-stage implant placement: A randomized controlled trial. Journal of Clinl Diagn Res 2015;9(4):ZC18–ZC21. DOI: 10.7860/JCDR/2015/12636.5788.
  7. Puisys A, Auzbikaviciute V, Minkauskaite A, et al. Early crestal bone loss: Is it really loss? Clin Case Rep 2019;7(10):1913–1915. DOI: 10.1002/ccr3.2376.
  8. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(6):638–646. DOI: 10.1016/s1079-2104(98)90029-4.
  9. Kon E, Filardo G, Di Martino A, et al. Platelet-rich plasma (PRP) to treat sports injuries: Evidence to support its use. Knee Surg Sports Traumatol Arthrosc 2011;19(4):516–527. DOI: 10.1007/s00167-010-1306-y.
  10. Tschon M, Fini M, Giardino R, et al. Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed) 2011;3(1):96–107. DOI: 10.2741/e224.
  11. Elkarargy A. The use of beta-tricalcium phosphate with platelet-rich plasma in maxillary anterior ridge expansion with simultaneous implant placement. Egyptian Dent J 2009;55. Available from: https://www.researchgate.net/publication/259298774_The_Use_Of_Beta-Tricalcium_Phosphate_With_Platelet-Rich_Plasma_In_Maxillary_Anterior_Ridge_Expansion_With_Simultaneous_Implant_Placement/link/00b4952aeb2095fd85000000/download?_tp=eyJjb250ZXh0Ijp7ImZpcnN0UGFnZSI6InB1YmxpY2F0a W9uIiwicGFnZSI6InB1YmxpY2F0aW9uIn19.
  12. Shalash M, Abdalsamad A. Crestal bone loss around tissue level implants with platform matching abutments versus bone level implants with conical/platform switched abutments in the posterior mandible: A comparative study. Bulletin of the National Research Centre 2020;44(1):184.
  13. Al Amri MD. Crestal bone loss around submerged and nonsubmerged dental implants: A systematic review. J Prosthet Dent 2016;115(5): 564–570.e1. DOI: 10.1016/j.prosdent.2015.11.002.
  14. Palacios-Garzón N, Velasco-Ortega E, López-López J. Bone loss in implants placed at subcrestal and crestal level: A systematic review and meta-analysis. Material 2019;12(1):154. DOI: 10.3390/ma12010154.
  15. Piattelli A, Vrespa G, Petrone G, et al. Role of the microgap between implant and abutment: A retrospective histologic evaluation in monkeys. J Periodontol 2003;74(3):346–352. DOI: 10.1902/jop.2003.74.3.346.
  16. Prasad DK, Shetty M, Bansal N, et al. Crestal bone preservation: A review of different approaches for successful implant therapy. Indian J Dent Res 2011;22(2):317–323. DOI: 10.4103/0970-9290.84311.
  17. Roffi A, Filardo G, Kon E, et al. Does PRP enhance bone integration with grafts, graft substitutes, or implants? A systematic review. BMC Musculoskelet Disord 2013;14:330. DOI: 10.1186/1471-2474-14-330.
  18. Hϋrzeler M, Fickl S, Zuhr O, et al. Peri-implant bone level around implants with platform switched abutments: Preliminary data from a prospective study. J Oral Maxillofac Surg 2007;65(7 Suppl 1):33–39. DOI: 10.1016/j.joms.2007.03.024.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.